DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
In the last 90 days, DBV Technologies S.A. insiders filed 0 open-market purchases and 1 sale; 78 institutions reported holding it in 13F filings for Q2 2026, worth $345.7M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Q3 2022 vs. Q2 2022
How the institutions holding DBV Technologies S.A. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 36 | −1 |
| Shares | 26.0M | 101 | 34.5M | +8.59M (+33.1%) |
| Value | $66.8M | $258 | $61.1M | −$5.63M (−8.4%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held DBV Technologies S.A. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ra Capital Management, L.P. | 3,724,740 | $6.59M | 0.14% |
| Vivo Capital, LLC | 2,708,875 | $4.79M | 0.53% |
| Millennium Management LLC | 566,434 | $1.00M | 0.00% |
| Envestnet Asset Management Inc | 38,028 | $67.0K | 0.00% |
| Optiver Holding B.V. | 20,172 | $36.0K | 0.00% |
| Commonwealth Equity Services, LLC | 14,700 | $26.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,309 | $7.00K | 0.00% |
Sold out (8)
Institutions that held DBV Technologies S.A. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ikarian Capital, LLC | 316,939 | $1.40M |
| Schonfeld Strategic Advisors LLC | 183,867 | $469.0K |
| Toroso Investments, LLC | 51,584 | $132.0K |
| Boothbay Fund Management, LLC | 32,861 | $84.0K |
| Geneos Wealth Management Inc. | 14,713 | $35.0K |
| Kestra Advisory Services, LLC | 11,100 | $28.0K |
| Advisory Services Network, LLC | 10,000 | $26.0K |
| Parallel Advisors, LLC | 378 | $1.00K |
Not filed for Q3 2022 yet (1)
Institutions that held DBV Technologies S.A. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exane Derivatives | 101 | $258 |